Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 1Advanced Malignant Solid Neoplasm 1

Interventions

Educational Status 3Methods 2Interviews as Topic 2Early Intervention, Educational 2veliparib 1pamiparib 1dinaciclib 1cabozantinib 1Specimen Handling 1Pharmacogenomic Variants 1Palliative Care 1Paclitaxel 1Nutrition Assessment 1Health Promotion 1Diet Therapy 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Malignant Solid Neoplasm × dinaciclib × 90 days × Clear all
NCT01434316 2026-04-13

Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Active not recruiting
121 enrolled
Other solid neoplasm

Advanced Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡